Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial

In a prospective, multicenter, open-label study, de novo liver transplant patients were randomized at day 30±5 to (i) everolimus initiation with tacrolimus elimination (TAC Elimination) (ii) everolimus initiation with reduced-exposure tacrolimus (EVR+Reduced TAC) or (iii) standard-exposure tacrolimu...

Descripción completa

Detalles Bibliográficos
Autores principales: De Simone, P, Nevens, F, De Carlis, L, Metselaar, H J, Beckebaum, S, Saliba, F, Jonas, S, Sudan, D, Fung, J, Fischer, L, Duvoux, C, Chavin, K D, Koneru, B, Huang, M A, Chapman, W C, Foltys, D, Witte, S, Jiang, H, Hexham, J M, Junge, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Inc 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533764/
https://www.ncbi.nlm.nih.gov/pubmed/22882750
http://dx.doi.org/10.1111/j.1600-6143.2012.04212.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533764/
https://www.ncbi.nlm.nih.gov/pubmed/22882750
http://dx.doi.org/10.1111/j.1600-6143.2012.04212.x

Ejemplares similares